Evidence map›Paper›PMID 24994818›Full record

ArticleInternational immunology2014

Enhanced auto-antibody production and Mott cell formation in FcμR-deficient autoimmune mice.

Kazuhito Honjo, Yoshiki Kubagawa, Yusuke Suzuki, Miyuki Takagi, Hiroshi Ohno, R Pat Bucy, Shozo Izui, Hiromi Kubagawa

Open access · bronzeAbstract read
In one paragraph

Article in International immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Secreted IgM: New tricks for an old molecule.Journal of leukocyte biology · 2019
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Kazuhito HonjoDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Yoshiki KubagawaDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Yusuke SuzukiDepartment of Internal Medicine, Division of Nephrology, Juntendo University School of Medicine, Tokyo 113-8421, Japan.
Miyuki TakagiDepartment of Internal Medicine, Division of Nephrology, Juntendo University School of Medicine, Tokyo 113-8421, Japan.
Hiroshi OhnoLaboratory for Intestinal Ecosystem, RIKEN Center for Integrative Medical Sciences, Yokohama 230-0045, Japan.
R Pat BucyDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Shozo IzuiDepartment of Pathology and Immunology, University of Geneva, 1211 Geneva 4, Switzerland.
Hiromi KubagawaDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA hiromikubagawa@uab.edu.
University of Alabama at Birmingham · USJuntendo University · JPRIKEN Center for Integrative Medical Sciences · JPUniversity of Geneva · CH

Funding

IgM Fc receptor in CLLR21AI094625 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KUBAGAWA, HIROMI · 2012 to 2013
$403k
Studies of structure and function of an Fc receptor for IgMR56AI082249 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KUBAGAWA, HIROMI · 2010 to 2010
$349k
NIAID NIH HHS R21 AI094625NIAID NIH HHS R56 AI82249
6 · The paper itself

Abstract

The IgM-Fc receptor (FcμR) is involved in IgM homeostasis as evidenced by increased pre-immune serum IgM and natural auto-antibodies of both IgM and IgG isotypes in Fcmr-deficient C57BL/6 (B6) mice. To determine the impact of Fcmr-ablation on autoimmunity, we introduced the Fcmr null mutation onto the Fas-deficient autoimmune-prone B6.MRL Fas (lpr/lpr) mouse background (B6/lpr). Both IgM and IgG auto-antibodies against dsDNA or chromatin appeared earlier in FcμR(-) B6/lpr than FcμR(+) B6/lpr mice, but this difference became less pronounced with age. Splenic B2 cells, which were 2-fold elevated in FcμR(+) B6/lpr mice, were reduced to normal B6 levels in FcμR(-) B6/lpr mice, whereas splenic B1 cells were comparable in both groups of B6/lpr mice. By contrast, marginal zone (MZ) B cells were markedly reduced in FcμR(-) B6/lpr mice compared with either FcμR(+) B6/lpr or wild type (WT) B6 mice. This reduction appeared to result from rapid differentiation of MZ B cells into plasma cells in the absence of FcμR, as IgM antibody to a Smith (Sm) antigen, to which MZ B cells are known to preferentially respond, was greatly increased in both groups (B6/lpr and B6) of FcμR(-) mice compared with FcμR(+) B6/lpr or B6 mice. Mott cells, aberrant plasma cells with intra-cytoplasmic inclusions, were also increased in the absence of FcμR. Despite these abnormalities, the severity of renal pathology and function and survival were all indistinguishable between FcμR(-) and FcμR(+) B6/lpr mice. Collectively, these findings suggest that FcμR plays important roles in the regulation of auto-antibody production, Mott cell formation and the differentiation of MZ B cells into plasma cells in B6.MRL Fas (lpr/lpr) mice.

Indexed as

AnimalsAntibody FormationAutoantibodiesAutoimmunityB-Lymphocyte SubsetsDisease Models, AnimalFemaleGene ExpressionLymphocyte CountMiceMice, Inbred MRL lprMice, KnockoutNephritisPlasma CellsReceptors, FcRibonucleoproteins, Small NuclearAutoantibodiesimmunoglobulin M receptorReceptors, FcRibonucleoproteins, Small Nuclearauto-antibodyFcμRIgMmarginal zone B cellsMott cells

Identifiers

PMID24994818
PMCPMC4242241
OpenAlexW2329429273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.